Уноси

• The use of unproven drugs for COVID-19 treatment in people living with HIV. (2023-06)

  J. Kowalska, B. Rozplochowski, A. Harxhi, L. Fleischhans, S. Antonjak, D. Gokengin, A. Vassilenko, K. Almla, A. Papadopoulus, R. Matulionyte, N. Rukhadze, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, A. Horban, The use of unproven drugs for COVID-19 treatment in people living with HIV., Jun, 2023

• Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

  J. Kowalska, D. Bursa, D. Jilich, S. Antoniak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, L. Fleishhans, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, 2022